TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Sanofi-Aventis Norge AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
498,097
|
487,434
|
547,738 |
Financial expenses |
865
|
925
|
755 |
Earnings before taxes |
27,847
|
42,070
|
21,686 |
Total assets |
233,296
|
281,739
|
243,218 |
Current assets |
231,603
|
279,938
|
240,913 |
Current liabilities |
229,800
|
245,748
|
128,191 |
Equity capital |
3,496
|
35,990
|
115,028 |
- share capital |
1,207
|
1,286
|
1,357 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
1.5%
|
12.8%
|
47.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
5.6%
|
8.6%
|
4.0% |
Return on assets (ROA) |
12.3%
|
15.3%
|
9.2% |
Current ratio |
100.8%
|
113.9%
|
187.9% |
Return on equity (ROE) |
796.5%
|
116.9%
|
18.9% |
Change turnover |
40,614
|
-31,533
|
30,092 |
Change turnover % |
9%
|
-6%
|
6% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.